Anticoagulation therapy: Bivalirudin not superior to heparin in PCI. [electronic resource]
- Nature reviews. Cardiology Nov 2017
- 632 p. digital
Publication Type: Journal Article; Review
1759-5010
10.1038/nrcardio.2017.142 doi
Acute Coronary Syndrome--drug therapy Anticoagulants--therapeutic use Antithrombins--therapeutic use Heparin--therapeutic use Hirudins Humans Peptide Fragments--therapeutic use Percutaneous Coronary Intervention Randomized Controlled Trials as Topic Recombinant Proteins--therapeutic use